Reason/Issue |
On November 28, 2017, the Therapeutic Goods Administration (TGA) notified Coloplast of TGA’s decision to remove transvaginal mesh products used to treat Pelvic Organ Prolapse (POP), and single incision mini-slings from the Australian Register of Therapeutic Goods (ARTG), effective January 4, 2018.
The TGA believes there is currently a lack of adequate scientific evidence for it to be satisfied that the risks to patients are outweighed by the benefits of these devices.
Further information can be found on the TGA website.
Following this direction from TGA, Coloplast is recalling all Restorelle DirectFix Anterior, Restorelle DirectFix Posterior, and Altis Single Incision Sling products from the Australian market.
No other Coloplast devices are affected by this recall. |